abstract |
The present invention relates to novel compounds of formula (I) which are capable of inhibiting the activity of Fab I enzymes, which are useful for the treatment of bacterial infections. Furthermore, the present invention relates to pharmaceutical compositions comprising these compounds and to chemical processes for making these compounds. |